Navigation Links
Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
Date:8/5/2013

ll cost of borrowing with lower credit spreads.

"Our Radiation Measurement and Medical Physics segments are performing as we had planned at their respective operating income levels when guidance for FY 2013 was originally communicated last November, but unplanned market challenges in our Medical Products business have caused us to take an impairment charge and lower EBITDA and net income guidance for FY 2013," stated Bill Saxelby, President and CEO of Landauer.

"The core Radiation Measurement business continues to perform in line with our expectations for FY 2013 and we are taking steps to improve global efficiency and reduce costs which are a byproduct of creating the management structure around this segment announced in FY 2012. These changes are primarily affecting our European operations. The operating margin performance in our Medical Physics business reflects the positive momentum generated by our profitability improvement initiatives over the last several quarters, and we see increased interest from large hospital systems regarding our enterprise wide radiation safety solution driving opportunities for future growth.  In the Medical Products business the new management team's leadership and direction, sales structure changes and product development efforts  have begun to show results in an improved revenue run rate, a significantly improved revenue pipeline for the business, and new business development opportunities.  Despite the disappointing year to date results for this business, we are confident that we have the right team and strategy in place to drive profitable growth long-term in this high margin consumable segment."

"We have taken proactive steps to improve the performance of our traditional Radiation Measurement business and Medical Physics businesses while addressing the competitive sales environment in our Medical Products business. Our focus will continue to be on generating free cash flow to invest in futu
'/>"/>

SOURCE Landauer, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
4. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
5. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
6. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
7. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
8. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
9. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
10. PDI Reports 2013 Second Quarter Financial Results
11. U.S. Orthopedic Biomaterials Market & Global Biomaterials Industry Reviewed by Products and Applications in New Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... released their latest predictive use case focused on helping hospital perform under the ... this program, hospital payments are adjusted based on performance across four domains related ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental ... Western University of Health Sciences to learn more about its integrated approach to ... Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... today their new “ InstantQuote ” tool, which summarizes all available plans, plan ... The technology tool is designed to help India Network members make an informed ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Coast Dental Vista ... 2015, from 11 a.m. to 3 p.m. near Albertsons in the Foothill Center, located ... meet Dr. Ofelia Rivera and Dr. Jay Lopp. Call (760) 208-2518 for more details ...
Breaking Medicine News(10 mins):Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3
... Hospital, Bangalore, have removed a large cancerous tumour from a ... statement that Prabhu Ram was diagnosed to be ailing from ... to difficulty in breathing, high fever and swelling of the ... arising from both the upper chambers of the heart, blocking ...
... German pharmaceutical company Grunenthal GmbH presented the first ... tapentadol ER (extended release) for patients suffering from ... the European League Against Rheumatism (EULAR), 13-16 June ... is the first of its kind, combining two ...
... Pennsylvania School of Medicine have identified proteins in the rod ... discovery of the genetic causes of a host of ... understanding of what goes wrong at the most basic level ... ,Specifically, they have identified and measured the types and ...
... no protection from harmful rays emitted by the sun and ... may even risk blindness, warn scientists in Britain. ... this radiation may severely affect the skin, eyes or the ... often choose sunglasses purely on the basis of their price ...
... hopes to benefit from the ban on smoking and they ... success of the ban. The Smoking ban, in public places, ... support from the public of Britain. Three quarter of the ... for an opening in areas where smokers are most likely ...
... are a $22 billion industry in the US. But ... concerns over the ingredients that go into the making of ... it is phasing in a new rule making for mandatory ... ,Frequently it has been pointed out that in many cases ...
Cached Medicine News:Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 2Health News:Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment 3Health News:Genetic Cause of Inherited Eye Diseases Identified 2Health News:Wear Protective Sunglasses, Not Just for Style 2Health News:Pubs Propose to Sell Nicotine Gum Patches 2Health News:US FDA Wants Vitamin Manufacturers to Test All Ingredients 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: